Xiayuxue Decoction (下瘀血汤) attenuates hepatic stellate cell activation and sinusoidal endothelium defenestration in CCl4-induced fibrotic liver of mice

被引：4
|
作者：
Li-jun Zhang
Ming-yu Sun
Bing-bing Ning
Wen-meng Zhang
Gao-feng Chen
Yong-ping Mu
Hua Zhang
Jia Liu
Yan-qin Bian
Ping Liu
机构：
[1] Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Institute of Liver Diseases
[2] Shanghai Municipal Education Commission,E
[3] Shanghai University of Traditional Chinese Medicine,Institute of Traditional Chinese Internal Medicine
来源：
Chinese Journal of Integrative Medicine | 2014年 / 20卷
关键词：
liver fibrosis; cirrhosis; hepatic stellate cell; liver sinusoidal endothelial cell; Xiayuxue Decoction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：516 / 523
页数：7
相关论文
共 47 条
  • [41] PBI-4050 Inhibits Stellate Cell Activation through the LKB1-AMPK-mTOR Signaling Axis, and Reduces CCl4-Induced Liver Fibrosis and Bile Duct Ligation-Induced Liver Fibrosis in Animal Models
    Sarra-Bournet, Francois
    Grouix, Brigitte
    Geerts, Lilianne
    Hince, Kathy
    Tremblay, Mikael
    Felton, Alexandra
    Blais, Alexandra
    Ouboudinar, Jugurtha
    Simard, Jean-Christophe
    Laurin, Pierre
    Gagnon, Lyne
    HEPATOLOGY, 2018, 68 : 631A - 632A
  • [42] RETRACTED ARTICLE: Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways
    Cheng Liu
    Xia Yuan
    Le Tao
    Zhuoan Cheng
    Xiuqin Dai
    Xia Sheng
    Dongying Xue
    BMC Complementary Medicine and Therapies, 15
  • [43] Retraction Note: Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways
    Cheng Liu
    Xia Yuan
    Le Tao
    Zhuoan Cheng
    Xiuqin Dai
    Xia Sheng
    Dongying Xue
    BMC Complementary Medicine and Therapies, 22
  • [44] RETRACTED: Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways (Retracted Article)
    Liu, Cheng
    Yuan, Xia
    Tao, Le
    Cheng, Zhuoan
    Dai, Xiuqin
    Sheng, Xia
    Xue, Dongying
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 15
  • [45] RETRACTION: Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways (Retraction of Vol 15, art no 201, 2015)
    Liu, Cheng
    Yuan, Xia
    Tao, Le
    Cheng, Zhuoan
    Dai, Xiuqin
    Sheng, Xia
    Xue, Dongying
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2022, 22 (01)
  • [46] The mouse Anxa6/miR-9-5p/Anxa2 axis modulates TGF-?1-induced mouse hepatic stellate cell (mHSC) activation and CCl4-caused liver fibrosis
    Liao, Jinmao
    Zhang, Zheng
    Yuan, Qi
    Luo, Lidan
    Hu, Xiaoxuan
    TOXICOLOGY LETTERS, 2022, 362 : 38 - 49
  • [47] SENESCENCE MARKER PROTEIN-30 (SMP30) DEFICIENCY IN MICE AMELIORATES CCL4-INDUCED LIVER FIBROSIS VIA DECREASED NUCLEAR EXPRESSION OF P-SMAD2/3 IN HEPATIC STELLATE CELLS AND IMBALANCE BETWEEN ANGIOTENSIN II RECEPTOR TYPE I (AT1) AND TYPE II (AT2) EXPRESSION
    Park, Jin-Kyu
    Ki, Mi-Ran
    Hong, Il-Hwo
    Ji, Ae-Ri
    Hong, Kyung-Sook
    Park, Sang-Joon
    Jeong, Kyu-Shik
    HEPATOLOGY, 2009, 50 (04) : 835A - 835A
12345